This information was published on 2026-01-01T06:30:37 for IP Right Filed Published.
| Field | Value |
| (210) | 2616078 (IR 1895066) |
| (220) |
19 Nov 2025
|
| (300) |
US, 18 Nov 2025, 99503488
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment of erythropoietic porphyria (EPP), X-linked protoporphyria (XLPP), genetic diseases and disorders, dermatological diseases and disorders, hematological diseases and disorders, liver diseases and disorders, and photosensitivity. Class 10 Medical tools being devices for diagnosing erythropoietic protoporphyria; medical tools being devices for treating and diagnosing sun exposure. Class 42 Research and development of pharmaceuticals and biologics for the treatment of immunologic disorders, hematologic disorders, anemia disorders, oncologic disorders and renal disorders; none of the foregoing offered in connection with treatment of diseases or disorders relating to spinal discs; scientific research and development in the field of sun exposure and related disease risk; research and development of pharmaceuticals, biologic preparations and medicines in the field of sun exposure and related disease risk; medical research and development in the field of sun exposure and related disease risk; conducting surveys and questionnaires being surveys to detect sun exposure and related disease risk. |
| (540) | DISC MEDICINE |
| (550) | Word |
| (730) |
Disc Medicine, Inc.
|
Find out more about publications on the About page.